Works by Kadowaki, Shigenori

Results: 82

Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5‐Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study.

Published in:

Cancer Medicine, 2025, v. 14, n. 9, p. 1, doi. 10.1002/cam4.70889

By:

Kumanishi, Ryosuke;
Taniguchi, Hiroya;
Nakazawa, Taiko;
Ogata, Takatsugu;
Matsubara, Yuki;
Kodama, Hiroyuki;
Nakata, Akinobu;
Honda, Kazunori;
Masuishi, Toshiki;
Narita, Yukiya;
Kadowaki, Shigenori;
Ando, Masashi;
Tajika, Masahiro;
Abe, Tetsuya;
Muro, Kei

Publication type:

Article

ASO Visual Abstract: Conversion from Radical Esophagectomy to Definitive Chemoradiotherapy after Neoadjuvant Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: Treatment Options Based on Chemotherapy Response.

Published in:

2025

By:

Narita, Kiyoshi;
Higaki, Eiji;
Abe, Tetsuya;
Fujieda, Hironori;
Hashimoto, Shingo;
Kadowaki, Shigenori;
Tajika, Masahiro;
Kodaira, Takeshi;
Muro, Kei;
Shimizu, Yasuhiro

Publication type:

Abstract

A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.

Published in:

Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 228, doi. 10.1093/jjco/hyv193

By:

Hiroya Taniguchi;
Azusa Komori;
Yukiya Narita;
Shigenori Kadowaki;
Takashi Ura;
Masashi Andoh;
Yasushi Yatabe;
Koji Komori;
Kenichi Kimura;
Takashi Kinoshita;
Kei Muro

Publication type:

Article

Clinical Outcome of Japanese Metastatic Colorectal Cancer Patients Harbouring the KRAS p.G13D Mutation Treated with Cetuximab + Irinotecan.

Published in:

Japanese Journal of Clinical Oncology, 2012, v. 42, n. 12, p. 1146, doi. 10.1093/jjco/hys160

By:

Bando, Hideaki;
Yoshino, Takayuki;
Yuki, Satoshi;
Shinozaki, Eiji;
Nishina, Tomohiro;
Kadowaki, Shigenori;
Yamazaki, Kentaro;
Kajiura, Shinya;
Tsuchihara, Katsuya;
Fujii, Satoshi;
Yamanaka, Takeharu;
Ohtsu, Atsushi

Publication type:

Article

Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan.

Published in:

Japanese Journal of Clinical Oncology, 2009, v. 39, n. 4, p. 225, doi. 10.1093/jjco/hyp002

By:

Kiyota, Naomi;
Tahara, Makoto;
Kadowaki, Shigenori;
Fuse, Nozomu;
Doi, Toshihiko;
Minami, Hironobu;
Ohtsu, Atsushi

Publication type:

Article

An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7).

Published in:

Cancers, 2021, v. 13, n. 4, p. 805, doi. 10.3390/cancers13040805

By:

Kawakami, Hisato;
Hironaka, Shuichi;
Esaki, Taito;
Chayama, Kazuaki;
Tsuda, Masahiro;
Sugimoto, Naotoshi;
Kadowaki, Shigenori;
Makiyama, Akitaka;
Machida, Nozomu;
Hirano, Hidekazu;
Hirata, Kenro;
Hara, Hiroki;
Yabusaki, Hiroshi;
Komatsu, Yoshito;
Muro, Kei;
Wijnhoven, Bas

Publication type:

Article

A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies.

Published in:

2020

By:

Mitani, Seiichiro;
Kadowaki, Shigenori;
Komori, Azusa;
Kondoh, Chihiro;
Oze, Isao;
Kato, Kyoko;
Masuishi, Toshiki;
Honda, Kazunori;
Narita, Yukiya;
Taniguchi, Hiroya;
Ando, Masashi;
Tanaka, Tsutomu;
Tajika, Masahiro;
Muro, Kei

Publication type:

journal article

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies.

Published in:

Case Reports in Oncology, 2019, v. 12, n. 1, p. 304, doi. 10.1159/000499705

By:

Mitani, Seiichiro;
Kadowaki, Shigenori;
Kato, Kyoko;
Masuishi, Toshiki;
Muro, Kei

Publication type:

Article

Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy.

Published in:

2016

By:

Mitani, Seiichiro;
Kadowaki, Shigenori;
Taniguchi, Hiroya;
Muto, Hisanori;
Muro, Kei

Publication type:

Case Study

Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy.

Published in:

Case Reports in Oncology, 2014, v. 7, n. 1, p. 210, doi. 10.1159/000362088

By:

Kadowaki, Shigenori;
Yatabe, Yasushi;
Nitta, Sohei;
Ito, Yuichi;
Muro, Kei

Publication type:

Article

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.

Published in:

Case Reports in Oncology, 2013, v. 6, n. 3, p. 450, doi. 10.1159/000355219

By:

Kadowaki, Shigenori;
Yatabe, Yasushi;
Hirakawa, Hitoshi;
Komori, Azusa;
Kondoh, Chihiro;
Hasegawa, Yasuhisa;
Muro, Kei

Publication type:

Article

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.

Published in:

Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835918820298

By:

Mitani, Seiichiro;
Taniguchi, Hiroya;
Sugiyama, Keiji;
Masuishi, Toshiki;
Honda, Kazunori;
Narita, Yukiya;
Kadowaki, Shigenori;
Ura, Takashi;
Ando, Masashi;
Tajika, Masahiro;
Yatabe, Yasushi;
Muro, Kei

Publication type:

Article

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.

Published in:

Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835918820298

By:

Mitani, Seiichiro;
Taniguchi, Hiroya;
Sugiyama, Keiji;
Masuishi, Toshiki;
Honda, Kazunori;
Narita, Yukiya;
Kadowaki, Shigenori;
Ura, Takashi;
Ando, Masashi;
Tajika, Masahiro;
Yatabe, Yasushi;
Muro, Kei

Publication type:

Article

Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic Cancers.

Published in:

Clinical Colorectal Cancer, 2023, v. 22, n. 3, p. 298, doi. 10.1016/j.clcc.2023.05.002

By:

Hiroyuki Kodama;
Toshiki Masuishi;
Munehiro Wakabayashi;
Akinobu Nakata;
Ryosuke Kumanishi;
Taiko Nakazawa;
Takatsugu Ogata;
Yuki Matsubara;
Kazunori Honda;
Yukiya Narita;
Hiroya Taniguchi;
Shigenori Kadowaki;
Masashi Ando;
Kei Muro

Publication type:

Article

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.

Published in:

2017

By:

Masuishi, Toshiki;
Taniguchi, Hiroya;
Hamauchi, Satoshi;
Komori, Azusa;
Kito, Yosuke;
Narita, Yukiya;
Tsushima, Takahiro;
Ishihara, Makoto;
Todaka, Akiko;
Tanaka, Tsutomu;
Yokota, Tomoya;
Kadowaki, Shigenori;
Machida, Nozomu;
Ura, Takashi;
Fukutomi, Akira;
Ando, Masashi;
Onozawa, Yusuke;
Tajika, Masahiro;
Yasui, Hirofumi;
Muro, Kei

Publication type:

journal article

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102.

Published in:

2017

By:

Satoshi Hamauchi;
Kentaro Yamazaki;
Toshiki Masuishi;
Yosuke Kito;
Azusa Komori;
Takahiro Tsushima;
Yukiya Narita;
Akiko Todaka;
Makoto Ishihara;
Tomoya Yokota;
Tsutomu Tanaka;
Nozomu Machida;
Shigenori Kadowaki;
Akira Fukutomi;
Takashi Ura;
Yusuke Onozawa;
Masashi Ando;
Masahiro Tajika;
Kei Muro;
Hirofumi Yasui

Publication type:

journal article

Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 3, p. 480, doi. 10.1007/s10147-025-02698-1

By:

Kodama, Hiroyuki;
Kadowaki, Shigenori;
Ishizuka, Yasunobu;
Wakabayashi, Munehiro;
Sakakida, Tomoki;
Honda, Kazunori;
Masuishi, Toshiki;
Narita, Yukiya;
Taniguchi, Hiroya;
Ando, Masashi;
Kishikawa, Toshihiro;
Terada, Hoshino;
Beppu, Shintaro;
Nishikawa, Daisuke;
Suzuki, Hidenori;
Hanai, Nobuhiro;
Muro, Kei

Publication type:

Article

Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 801, doi. 10.1007/s10147-024-02509-z

By:

Wakatsuki, Takeru;
Ishizuka, Naoki;
Hironaka, Shuichi;
Minashi, Keiko;
Kadowaki, Shigenori;
Goto, Masahiro;
Shoji, Hirokazu;
Hirano, Hidekazu;
Nakayama, Izuma;
Osumi, Hiroki;
Ogura, Mariko;
Chin, Keisho;
Yamaguchi, Kensei;
Takahari, Daisuke

Publication type:

Article

Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 764, doi. 10.1007/s10147-024-02508-0

By:

Iwaki, Sho;
Kadowaki, Shigenori;
Honda, Kazunori;
Narita, Yukiya;
Masuishi, Toshiki;
Taniguchi, Hiroya;
Ando, Masashi;
Muro, Kei;
Sawabe, Michi;
Suzuki, Hidenori;
Nishikawa, Daisuke;
Beppu, Shintaro;
Terada, Hoshino;
Kishikawa, Toshihiro;
Kawakita, Daisuke;
Hanai, Nobuhiro

Publication type:

Article

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition

Published in:

International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1237, doi. 10.1007/s10147-023-02397-9

By:

Mishima, Saori;
Naito, Yoichi;
Akagi, Kiwamu;
Hayashi, Naomi;
Hirasawa, Akira;
Hishiki, Tomoro;
Igarashi, Ataru;
Ikeda, Masafumi;
Kadowaki, Shigenori;
Kajiyama, Hiroaki;
Kato, Motohiro;
Kenmotsu, Hirotsugu;
Kodera, Yasuhiro;
Komine, Keigo;
Koyama, Takafumi;
Maeda, Osamu;
Miyachi, Mitsuru;
Nishihara, Hiroshi;
Nishiyama, Hiroyuki;
Ohga, Shouichi

Publication type:

Article

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.

Published in:

International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 941, doi. 10.1007/s10147-023-02360-8

By:

Mishima, Saori;
Naito, Yoichi;
Akagi, Kiwamu;
Hayashi, Naomi;
Hirasawa, Akira;
Hishiki, Tomoro;
Igarashi, Ataru;
Ikeda, Masafumi;
Kadowaki, Shigenori;
Kajiyama, Hiroaki;
Kato, Motohiro;
Kenmotsu, Hirotsugu;
Kodera, Yasuhiro;
Komine, Keigo;
Koyama, Takafumi;
Maeda, Osamu;
Miyachi, Mitsuru;
Nishihara, Hiroshi;
Nishiyama, Hiroyuki;
Ohga, Shouichi

Publication type:

Article

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors

Published in:

International Journal of Clinical Oncology, 2023, v. 28, n. 7, p. 827, doi. 10.1007/s10147-023-02345-7

By:

Naito, Yoichi;
Mishima, Saori;
Akagi, Kiwamu;
Hayashi, Naomi;
Hirasawa, Akira;
Hishiki, Tomoro;
Igarashi, Ataru;
Ikeda, Masafumi;
Kadowaki, Shigenori;
Kajiyama, Hiroaki;
Kato, Motohiro;
Kenmotsu, Hirotsugu;
Kodera, Yasuhiro;
Komine, Keigo;
Koyama, Takafumi;
Maeda, Osamu;
Miyachi, Mitsuru;
Nishihara, Hiroshi;
Nishiyama, Hiroyuki;
Ohga, Shouichi

Publication type:

Article

Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.

Published in:

International Journal of Clinical Oncology, 2023, v. 28, n. 6, p. 756, doi. 10.1007/s10147-023-02330-0

By:

Kumanishi, Ryosuke;
Kadowaki, Shigenori;
Mitani, Seiichiro;
Matsushima, Tomohiro;
Ogata, Takatsugu;
Narita, Yukiya;
Masuishi, Toshiki;
Bando, Hideaki;
Tajika, Masahiro;
Yasui, Hisateru;
Hara, Hiroki;
Muro, Kei

Publication type:

Article

Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.

Published in:

International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 644, doi. 10.1007/s10147-023-02316-y

By:

Ando, Masashi;
Honda, Kazunori;
Hosoda, Waki;
Matsubara, Yuki;
Kumanishi, Ryosuke;
Nakazawa, Taiko;
Ogata, Takatsugu;
Nakata, Akinobu;
Kodama, Hiroyuki;
Masuishi, Toshiki;
Narita, Yukiya;
Taniguchi, Hiroya;
Kadowaki, Shigenori;
Muro, Kei

Publication type:

Article

Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2017, doi. 10.1007/s10147-021-01987-9

By:

Taniguchi, Hiroya;
Masuishi, Toshiki;
Kawazoe, Akihito;
Muro, Kei;
Kadowaki, Shigenori;
Bando, Hideaki;
Iino, Shuichi;
Kageyama, Rie;
Yoshino, Takayuki

Publication type:

Article

Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma.

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1188, doi. 10.1007/s10147-021-01907-x

By:

Motai, Risa;
Sawabe, Michi;
Kadowaki, Shigenori;
Sasaki, Eiichi;
Nishikawa, Daisuke;
Suzuki, Hidenori;
Beppu, Shintaro;
Terada, Hoshino;
Hanai, Nobuhiro

Publication type:

Article

A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 701, doi. 10.1007/s10147-020-01842-3

By:

Kadowaki, Shigenori;
Masuishi, Toshiki;
Ura, Takashi;
Sugiyama, Keiji;
Mitani, Seiichiro;
Narita, Yukiya;
Taniguchi, Hiroya;
Muro, Kei

Publication type:

Article

Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1197, doi. 10.1007/s10147-019-01477-z

By:

Mitani, Seiichiro;
Kadowaki, Shigenori;
Hasegawa, Hiroko;
Wakatsuki, Takeru;
Hara, Hiroki;
Tajika, Masahiro;
Nishikawa, Kazuhiro;
Hirao, Motohiro;
Takahari, Daisuke;
Chin, Keisho;
Muro, Kei

Publication type:

Article

First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake.

Published in:

International Journal of Clinical Oncology, 2018, v. 23, n. 2, p. 275, doi. 10.1007/s10147-017-1198-7

By:

Hara, Hiroki;
Kadowaki, Shigenori;
Asayama, Masako;
Ooki, Akira;
Yamada, Toko;
Yoshii, Takako;
Yamaguchi, Kensei

Publication type:

Article

Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.

Published in:

International Journal of Clinical Oncology, 2016, v. 21, n. 5, p. 890, doi. 10.1007/s10147-016-0963-3

By:

Nomura, Motoo;
Oze, Isao;
Kodaira, Takeshi;
Abe, Tetsuya;
Komori, Azusa;
Narita, Yukiya;
Masuishi, Toshiki;
Taniguchi, Hiroya;
Kadowaki, Shigenori;
Ura, Takashi;
Andoh, Masashi;
Tachibana, Hiroyuki;
Uemura, Norihisa;
Tajika, Masahiro;
Niwa, Yasumasa;
Muto, Manabu;
Muro, Kei

Publication type:

Article

Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.

Published in:

International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 755, doi. 10.1007/s10147-014-0772-5

By:

Narita, Yukiya;
Taniguchi, Hiroya;
Komori, Koji;
Kimura, Kenya;
Kinoshita, Takashi;
Komori, Azusa;
Nomura, Motoo;
Kadowaki, Shigenori;
Takahari, Daisuke;
Ura, Takashi;
Andoh, Masashi;
Muro, Kei

Publication type:

Article

Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.

Published in:

International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 656, doi. 10.1007/s10147-013-0610-1

By:

Kadowaki, Shigenori;
Komori, Azusa;
Narita, Yukiya;
Nitta, Sohei;
Yamaguchi, Kazuhisa;
Kondo, Chihiro;
Taniguchi, Hiroya;
Takahari, Daisuke;
Ura, Takashi;
Ando, Masashi;
Muro, Kei

Publication type:

Article

Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.

Published in:

JAMA Network Open, 2019, v. 2, n. 8, p. e198243, doi. 10.1001/jamanetworkopen.2019.8243

By:

Yoshikawa, Takaki;
Muro, Kei;
Shitara, Kohei;
Oh, Do-Youn;
Kang, Yoon-Koo;
Chung, Hyun Cheol;
Kudo, Toshihiro;
Chin, Keisho;
Kadowaki, Shigenori;
Hamamoto, Yasuo;
Hironaka, Shuichi;
Yoshida, Kazuhiro;
Yen, Chia-Jui;
Omuro, Yasushi;
Bai, Li-Yuan;
Maeda, Kaijiro;
Ozeki, Akichika;
Yoshikawa, Reigetsu;
Kitagawa, Yuko

Publication type:

Article

Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.

Published in:

2020

By:

Kawai, Sadayuki;
Fukuda, Naoki;
Yamamoto, Shun;
Mitani, Seiichiro;
Omae, Katsuhiro;
Wakatsuki, Takeru;
Kato, Ken;
Kadowaki, Shigenori;
Takahari, Daisuke;
Boku, Narikazu;
Muro, Kei;
Machida, Nozomu

Publication type:

journal article

TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.

Published in:

2020

By:

Bando, Hideaki;
Kotani, Daisuke;
Tsushima, Takahiro;
Hara, Hiroki;
Kadowaki, Shigenori;
Kato, Ken;
Chin, Keisho;
Yamaguchi, Kensei;
Kageyama, Shun-ichiro;
Hojo, Hidehiro;
Nakamura, Masaki;
Tachibana, Hidenobu;
Wakabayashi, Masashi;
Fukutani, Miki;
Togashi, Yosuke;
Fuse, Nozomu;
Nishikawa, Hiroyoshi;
Kojima, Takashi

Publication type:

journal article

Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer.

Published in:

Oncology Letters, 2017, v. 14, n. 2, p. 2545, doi. 10.3892/ol.2017.6409

By:

YUKIYA NARITA;
SHIGENORI KADOWAKI;
TOSHIKI MASUISHI;
HIROYA TANIGUCHI;
DAISUKE TAKAHARI;
TAKASHI URA;
MASASHI ANDO;
MASAHIRO TAJIKA;
YASUMASA NIWA;
TETSUYA ETO;
HIROKI HARA;
MASAKO ASAYAMA;
KENSEI YAMAGUCHI;
YASUSHI YATABE;
KEI MURO

Publication type:

Article

Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab.

Published in:

Cancers, 2018, v. 10, n. 12, p. 466, doi. 10.3390/cancers10120466

By:

Nishikawa, Daisuke;
Suzuki, Hidenori;
Koide, Yusuke;
Beppu, Shintaro;
Kadowaki, Shigenori;
Sone, Michihiko;
Hanai, Nobuhiro

Publication type:

Article

Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes.

Published in:

2004

By:

Kawakami, Keiki;
Miyanishi, Setsuko;
Sonoki, Takashi;
Nakamura, Shigeo;
Nomura, Kenichi;
Taniwaki, Masafumi;
Murata, Tetsuya;
Kadowaki, Shigenori;
Kadowaki, Norimitsu;
Miura, Ikuo

Publication type:

journal article

Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab.

Published in:

Cancer Science, 2021, v. 112, n. 1, p. 339, doi. 10.1111/cas.14706

By:

Nishikawa, Daisuke;
Suzuki, Hidenori;
Beppu, Shintaro;
Terada, Hoshino;
Sawabe, Michi;
Kadowaki, Shigenori;
Sone, Michihiko;
Hanai, Nobuhiro

Publication type:

Article

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma.

Published in:

Cancer Science, 2013, v. 104, n. 11, p. 1455, doi. 10.1111/cas.12274

By:

Hara, Hiroki;
Tahara, Makoto;
Daiko, Hiroyuki;
Kato, Ken;
Igaki, Hiroyasu;
Kadowaki, Shigenori;
Tanaka, Yoichi;
Hamamoto, Yasuo;
Matsushita, Hisayuki;
Nagase, Michitaka;
Hosoya, Yoshinori

Publication type:

Article

The interplay of KRAS mutational status with tumor laterality in non‐metastatic colorectal cancer: An international, multi‐institutional study in patients with known KRAS, BRAF, and MSI status.

Published in:

Journal of Surgical Oncology, 2021, v. 123, n. 4, p. 1005, doi. 10.1002/jso.26352

By:

Kamphues, Carsten;
Kadowaki, Shigenori;
Amini, Neda;
Berg, Inge;
Wang, Jaeyun;
Andreatos, Nikolaos;
Sakamoto, Yuki;
Ogura, Toshiro;
Kakuta, Miho;
Pikouli, Anastasia;
Geka, Despoina;
Daitoku, Nobuya;
Theochari, Maria;
Buettner, Stefan;
Akiyama, Takahiko;
Antoniou, Efstathios;
Pikoulis, Emmanouil;
Theodoropoulos, George;
Imai, Katsunori;
Ijzermans, Jan N. M.

Publication type:

Article

Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS: MSI-high unresectable gastric cancer...: A. Komori et al.

Published in:

Gastric Cancer, 2025, v. 28, n. 2, p. 301, doi. 10.1007/s10120-024-01579-2

By:

Komori, Azusa;
Hironaka, Shuichi;
Kadowaki, Shigenori;
Mitani, Seiichiro;
Furuta, Mitsuhiro;
Kawakami, Takeshi;
Makiyama, Akitaka;
Takegawa, Naoki;
Sugiyama, Keiji;
Hirano, Hidekazu;
Ando, Takayuki;
Matsushima, Tomohiro;
Chida, Akihiko;
Kashiwada, Tomomi;
Komoda, Masato;
Matsumoto, Toshihiko;
Oda, Hisanobu;
Yabusaki, Hiroshi;
Kawakami, Hisato;
Yamazaki, Kentaro

Publication type:

Article

Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial

Published in:

Gastric Cancer, 2024, v. 27, n. 6, p. 1287, doi. 10.1007/s10120-024-01535-0

By:

Boku, Narikazu;
Omori, Takeshi;
Shitara, Kohei;
Sakuramoto, Shinichi;
Yamaguchi, Kensei;
Kato, Ken;
Kadowaki, Shigenori;
Tsuji, Kunihiro;
Ryu, Min-Hee;
Oh, Do-Youn;
Oh, Sang Cheul;
Rha, Sun Young;
Lee, Keun-Wook;
Chung, Ik-Joo;
Sym, Sun Jin;
Chen, Li-Tzong;
Chen, Jen-Shi;
Bai, Li-Yuan;
Nakada, Takashi;
Hagihara, Shunsuke

Publication type:

Article

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.

Published in:

Gastric Cancer, 2023, v. 26, n. 1, p. 132, doi. 10.1007/s10120-022-01349-y

By:

Aoki, Masahiko;
Kadowaki, Shigenori;
Takahashi, Naoki;
Suzuki, Takeshi;
Oshima, Kotoe;
Ando, Takayuki;
Yamamoto, Yoshiyuki;
Kawakami, Kentaro;
Kito, Yosuke;
Matsumoto, Toshihiko;
Shimozaki, Keitaro;
Miyazaki, Yasuhiro;
Yamaguchi, Toshifumi;
Nagase, Michitaka;
Tamura, Takao;
Amanuma, Yusuke;
Esaki, Taito;
Miura, Yuji;
Akiyoshi, Kohei;
Baba, Eishi

Publication type:

Article

A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013).

Published in:

Gastric Cancer, 2022, v. 25, n. 6, p. 1082, doi. 10.1007/s10120-022-01317-6

By:

Kakeji, Yoshihiro;
Ishikawa, Takashi;
Suzuki, Satoshi;
Akazawa, Kohei;
Irino, Tomoyuki;
Miyashiro, Isao;
Ono, Hiroyuki;
Suzuki, Haruhisa;
Tanabe, Satoshi;
Kadowaki, Shigenori;
Muro, Kei;
Fukagawa, Takeo;
Nunobe, Souya;
Wada, Takeyuki;
Katai, Hitoshi;
Kodera, Yasuhiro

Publication type:

Article

Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry.

Published in:

Gastric Cancer, 2021, v. 24, n. 3, p. 545, doi. 10.1007/s10120-021-01178-5

By:

Suzuki, Satoshi;
Takahashi, Arata;
Ishikawa, Takashi;
Akazawa, Kohei;
Katai, Hitoshi;
Isobe, Yoh;
Miyashiro, Isao;
Ono, Hiroyuki;
Tanabe, Satoshi;
Fukagawa, Takeo;
Muro, Kei;
Nunobe, Souya;
Kadowaki, Shigenori;
Suzuki, Haruhisa;
Irino, Tomoyuki;
Usune, Shiyori;
Miyata, Hiroaki;
Kakeji, Yoshihiro;
The Registration Committee of the Japanese Gastric Cancer Association

Publication type:

Article

Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.

Published in:

Gastric Cancer, 2019, v. 22, n. 6, p. 1238, doi. 10.1007/s10120-019-00973-5

By:

Takahari, Daisuke;
Chin, Keisho;
Ishizuka, Naoki;
Takashima, Atsuo;
Minashi, Keiko;
Kadowaki, Shigenori;
Nishina, Tomohiro;
Nakajima, Takako Eguchi;
Amagai, Kenji;
Machida, Nozomu;
Goto, Masahiro;
Taku, Keisei;
Wakatsuki, Takeru;
Shoji, Hirokazu;
Hironaka, Shuichi;
Boku, Narikazu;
Yamaguchi, Kensei

Publication type:

Article

Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.

Published in:

Gastric Cancer, 2018, v. 21, n. 6, p. 1050, doi. 10.1007/s10120-018-0825-y

By:

Kondoh, Chihiro;
Kadowaki, Shigenori;
Komori, Azusa;
Narita, Yukiya;
Taniguchi, Hiroya;
Ura, Takashi;
Ando, Masashi;
Muro, Kei

Publication type:

Article

Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer.

Published in:

Gastric Cancer, 2018, v. 21, n. 1, p. 106, doi. 10.1007/s10120-017-0745-2

By:

Shitara, Kohei;
Kadowaki, Shigenori;
Nishina, Tomohiro;
Sakai, Daisuke;
Yoshikawa, Reigetsu;
Piao, Yongzhe;
Ozeki, Akihiro;
Inoue, Koichi;
Gritli, Ismael;
Muro, Kei

Publication type:

Article

Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.

Published in:

Gastric Cancer, 2016, v. 19, n. 1, p. 183, doi. 10.1007/s10120-015-0471-6

By:

Fuse, Nozomu;
Kuboki, Yasutoshi;
Kuwata, Takeshi;
Nishina, Tomohiro;
Kadowaki, Shigenori;
Shinozaki, Eiji;
Machida, Nozomu;
Yuki, Satoshi;
Ooki, Akira;
Kajiura, Shinya;
Kimura, Tetsuo;
Yamanaka, Takeharu;
Shitara, Kohei;
Nagatsuma, Akiko;
Yoshino, Takayuki;
Ochiai, Atsushi;
Ohtsu, Atsushi

Publication type:

Article